Nicholas Kitchin
Pfizer (United States)(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Viral gastroenteritis research and epidemiology, Bacterial Infections and Vaccines, Vaccine Coverage and Hesitancy, COVID-19 Clinical Research Studies
Most-Cited Works
- → Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine(2020)15,281 cited
- → Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates(2020)2,701 cited
- → Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults(2020)1,576 cited
- → Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents(2021)921 cited
- → Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age(2021)616 cited
- → SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3(2021)414 cited
- → Neutralization of BA.4–BA.5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent Vaccine(2023)175 cited
- → RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study(2020)155 cited
- → Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine(2021)143 cited
- → Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report(2020)123 cited